German biopharmaceutical company CureVac GmbH is the winner of the EU's first ever innovation inducement prize. The company received the prize for achieving progress towards a novel technology that aims to facilitate people’s access to vaccines. The European Commission hopes the €2 million prize will encourage inventors to work in order to address the biggest challenge to using vaccines in developing countries: the need to keep them stable at any ambient temperature.
As Máire Geoghegan-Quinn,...
This story is part of New Europe's Premium content.
|To Read the Full Story, Subscribe or Sign In from the ↑ Top of the Page ↑|